Advanced in Acute Kidney Failure

Eric S. Thervet

Paris, FR 
Advanced in Acute Kidney Failure
Paris, FR 
OverviewLocationsClinical Research

Overview

Eric Thervet practices in Paris, France. Mr. Thervet is rated as an Advanced expert by MediFind in the treatment of Acute Kidney Failure. His top areas of expertise are Chronic Kidney Disease, Acute Intermittent Porphyria, Glomerulonephritis, Acute Kidney Failure, and Kidney Transplant.

His clinical research consists of co-authoring 161 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Acute Kidney Failure.

Gender
Male

Locations

Paris, France
Other Locations
Boulogne-billancourt, France
Georges, France
Villejuif, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
Enrollment Status: Active_not_recruiting
Publish Date: June 12, 2025
Intervention Type: Drug
Study Drugs: Sparsentan, Irbesartan
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drug: Atrasentan
Study Phase: Phase 3
View 1 Less Clinical Trial

161 Total Publications

Impact of Corticosteroid-Free Regimen on Interstitial Fibrosis Following Kidney Transplantation.
Impact of Corticosteroid-Free Regimen on Interstitial Fibrosis Following Kidney Transplantation.
Journal: Kidney international reports
Published: November 04, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Thervet's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 55 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile